30,730 Danaher Corporation $DHR Shares Sold by HighTower Advisors LLC

HighTower Advisors LLC lessened its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 15.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 170,593 shares of the conglomerate’s stock after selling 30,730 shares during the quarter. HighTower Advisors LLC’s holdings in Danaher were worth $37,795,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. BlackRock Inc. acquired a new position in shares of Danaher during the second quarter worth $10,492,520,000. Wellington Management Group LLP lifted its holdings in shares of Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after purchasing an additional 1,542,310 shares during the last quarter. Jupiter Topco LLC acquired a new stake in shares of Danaher in the 2nd quarter worth $1,456,317,000. Generation Investment Management LLP acquired a new stake in shares of Danaher in the 2nd quarter worth $1,287,949,000. Finally, Bank of America Corp DE purchased a new position in Danaher during the 2nd quarter worth $993,846,000. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In other news, EVP Gregory M. Milosevich sold 2,100 shares of the company’s stock in a transaction on Monday, November 9th. The shares were sold at an average price of $230.62, for a total value of $484,302.00. Following the sale, the executive vice president directly owned 22,367 shares of the company’s stock, valued at $5,158,277.54. This represents a 8.58% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the sale, the chief accounting officer owned 9,107 shares in the company, valued at $2,136,137.92. The trade was a 45.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 10.80% of the company’s stock.

Danaher Stock Down 0.4%

Shares of DHR stock opened at $227.56 on Friday. The stock’s 50-day simple moving average is $224.42 and its 200-day simple moving average is $201.64. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. The firm has a market capitalization of $160.10 billion, a PE ratio of 27.41, a P/E/G ratio of 2.87 and a beta of 0.76. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm had revenue of $6.55 billion during the quarter, compared to analysts’ expectations of $6.56 billion. During the same period last year, the business posted $1.89 earnings per share. The company’s revenue for the quarter was up 8.3% compared to the same quarter last year. Equities analysts expect that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is currently 26.19%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on DHR. Stifel Nicolaus upped their target price on Danaher from $220.00 to $260.00 and gave the company a “buy” rating in a research report on Thursday, October 22nd. Robert W. Baird increased their price target on Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a research note on Thursday, October 22nd. TD Cowen raised their price target on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. Citigroup boosted their price target on Danaher from $230.00 to $270.00 and gave the stock a “buy” rating in a research note on Thursday, October 22nd. Finally, Royal Bank Of Canada upped their price objective on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $242.91.

Get Our Latest Stock Analysis on DHR

About Danaher

(Free Report)

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.